Is XNPT a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

475 people get XNPT articles and Market Currents by email alert.

Get email alerts on XNPT »

HEADLINES:

XenoPort's CEO Presents at Special Conference (Transcript)
Mon, May 20
XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multiple Sclerosis Patients

Business Wire (Mon, 6:30AM)
XenoPort Provides Update on Availability of Horizant

Business Wire (Fri, 8:30AM)
XenoPort Announces New Employment Inducement Awards

Business Wire (May 3, 2013)
XenoPort's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Wed, Apr 24
XenoPort Reports First Quarter Financial Results

Business Wire (Apr 24, 2013)
XenoPort: A High Probablity Run-Up Trade
bsiflingtrades • Thu, Apr 18 • 5 Comments
XenoPort to Release First Quarter Financial Results on April 24

Business Wire (Apr 17, 2013)
XenoPort Provides Update on Its Introduction of Horizant

Business Wire (Apr 12, 2013)
XenoPort Announces New Employment Inducement Awards

Business Wire (Apr 5, 2013)
XenoPort Announces Presentations at the American Academy of Neurology Meeting

Business Wire (Mar 18, 2013)
A Number Of Actionable Events For XenoPort, With Capital To Back Up The Company
PropThink • Tue, Mar 12
XenoPort's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Mon, Mar 11
XenoPort Reports Fourth Quarter and Year-End 2012 Financial Results

Business Wire (Mar 11, 2013)
XenoPort to Release Fourth Quarter and Year-End Financial Results on March 11, 2013

Business Wire (Mar 4, 2013)
XenoPort Announces New Employment Inducement Awards

Business Wire (Mar 4, 2013)
XenoPort to Present at the Cowen and Company 33rd Annual Health Care Conference

Business Wire (Mar 1, 2013)
XenoPort's CEO Presents at Citi 2013 Global Healthcare Conference (Transcript)
Wed, Feb 27
XenoPort to Present at Upcoming Healthcare Conferences

Business Wire (Feb 19, 2013)
XenoPort Announces New Employment Inducement Awards

Business Wire (Feb 4, 2013)

To learn more about Seeking Alpha Pro, click here.

XenoPort: A High Probablity Run-Up Trade
bsiflingtrades • Thu, Apr 18 • 5 Comments
A Number Of Actionable Events For XenoPort, With Capital To Back Up The Company
PropThink • Tue, Mar 12
XenoPort: Biogen's Little Brother And More
PropThink • Fri, Jan 18 • 2 Comments
Xenoport More Interesting After Washed Out Expectations
Stephen Simpson • Tue, Apr 10, 2012 • 5 Comments
Xenoport: Favorable Risk/Reward Ratio
Biomaven • Wed, May 11, 2011 • 3 Comments
XenoPort: Waiting for the Post-Approval Dust to Settle
Kinetic Investments • Fri, Apr 8, 2011 • 6 Comments
XenoPort: Bearish Approach to Trade PDUFA Event
Tony Pelz • Mon, Apr 4, 2011 • 4 Comments
Trading XenoPort's PDUFA Event
Tony Pelz • Tue, Mar 29, 2011 • 5 Comments
Xenoport Expecting GERD Study Data
Rockford Coscia • Thu, Feb 24, 2011 • 7 Comments
Hedge Fund Bridger Management Ups XenoPort Stake
Market Folly • Tue, Jul 20, 2010
Steven Cohen's SAC Capital Discloses New XenoPort Stake
Market Folly • Tue, May 25, 2010
XenoPort's Solzira a Potential Blockbuster
Zacks Investment Research • Wed, Jun 17, 2009

5 Pharmaceutical Companies With Phase III Clinical Study Catalysts During The Next 3 - 9 Months (Part II)
Markus Aarnio • Tue, Aug 21, 2012 • 4 Comments
Notable Insider Buys Filed On August 9
StockPandit • Fri, Aug 10, 2012 • 1 Comment
Glaxo And Human Genome Have Apparently Seen Reason
Stephen Simpson • Mon, Jul 16, 2012
Micro Cap Biotech Stocks Being Accumulated By The World's Largest Money Managers
GuruFundPicks • Wed, Jul 11, 2012 • 9 Comments
3 High-Growth Biotech Stocks Positively Correlated With Volatility
Kapitall • Fri, Jun 8, 2012 • 6 Comments
4 Speculative Biotech Trades In The Economic Downturn
Top Economic Articles • Mon, Jun 4, 2012 • 2 Comments
13 Healthcare Stocks With Major June Catalysts
Spencer Knight • Sun, Jun 3, 2012 • 10 Comments
5 Biotechnology Stocks With Upcoming Catalysts
Helix Investment Research • Wed, May 16, 2012 • 3 Comments
Selling An FDA Approval: Recent Results
BinaryLeverage • Wed, May 9, 2012 • 11 Comments
End Of Week Bio-Pharma Catalyst Trade And Watch List
Scott Matusow • Fri, May 4, 2012 • 46 Comments
6 Biotech Stocks With Huge Potential In June
StockPandit • Thu, May 3, 2012 • 3 Comments
Wednesday, April 18th Bio-Pharma Mover Watch List
Scott Matusow • Wed, Apr 18, 2012 • 9 Comments
Bio-Pharma Catalyst Trades That Offer Decent Short-Term Gains
Scott Matusow • Mon, Apr 9, 2012 • 5 Comments
Focus On Upcoming FDA Drug Approval And Advisory Dates
Scott Matusow • Wed, Apr 4, 2012 • 36 Comments
6 Highly Liquid Biotech Stocks With Positive Correlation To Volatility
Kapitall • Tue, Jan 31, 2012
4 Low-Priced Biotech Stocks Poised To Rally In 2012
Rougemont • Tue, Jan 24, 2012 • 4 Comments
11 Biotech Stocks With Bullish Short Trends
Kapitall • Wed, Nov 23, 2011
14 Oversold Tech Stocks Undervalued by Target Price
Kapitall • Tue, Nov 22, 2011
17 High-Growth Healthcare Stocks Being Bought Up By Hedge Funds
Kapitall • Sun, Nov 20, 2011 • 2 Comments
20 Oversold Stocks Deeply Undervalued By Target Price
Kapitall • Fri, Nov 11, 2011

XenoPort's CEO Presents at Special Conference (Transcript)
Mon, May 20
XenoPort's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Wed, Apr 24
XenoPort's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Mon, Mar 11
XenoPort's CEO Presents at Citi 2013 Global Healthcare Conference (Transcript)
Wed, Feb 27
XenoPort's CEO Presents at Credit Suisse 2012 Healthcare Conference (Transcript)
Wed, Nov 14, 2012
XenoPort's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Wed, Oct 24, 2012
XenoPort's CEO Hosts XenoPort XP23829 Clinical Trial Results Call (Transcript)
Sat, Oct 6, 2012
XenoPort's CEO Presents at Morgan Stanley Global Healthcare Conference (Transcript)
Tue, Sep 11, 2012
XenoPort Management Discusses at Wedbush Securities Conference - Conference Call Transcript
Tue, Aug 14, 2012
Xenoport's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Tue, Aug 7, 2012
XenoPort, Inc. Q2 2009 Earnings Call Transcript
Wed, Aug 5, 2009
XenoPort, Inc., Q1 2009 Earnings Call Transcript.
Tue, May 5, 2009
XenoPort Inc. Q4 2008 Earnings Call Transcript
Thu, Feb 12, 2009
XenoPort, Inc. Q3 2008 Earnings Call Transcript
Mon, Nov 24, 2008
XenoPort Inc.Q2 2008 Earnings Call Transcript
Wed, Aug 6, 2008
Xenoport, Inc. Q1 2008 Earnings Call Transcript
Tue, May 13, 2008
XenoPort Incorporated Q4 2007 Earnings Call Transcript
Thu, Feb 14, 2008
XenoPort Business Update Call Transcript
Tue, Jan 22, 2008
Xenoport Q3 2007 Earnings Call Transcript
Wed, Nov 7, 2007

XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multiple Sclerosis Patients

Business Wire (Mon, 6:30AM)
XenoPort Provides Update on Availability of Horizant

Business Wire (Fri, 8:30AM)
XenoPort Announces New Employment Inducement Awards

Business Wire (May 3, 2013)
XenoPort Reports First Quarter Financial Results

Business Wire (Apr 24, 2013)
XenoPort to Release First Quarter Financial Results on April 24

Business Wire (Apr 17, 2013)
XenoPort Provides Update on Its Introduction of Horizant

Business Wire (Apr 12, 2013)
XenoPort Announces New Employment Inducement Awards

Business Wire (Apr 5, 2013)
XenoPort Announces Presentations at the American Academy of Neurology Meeting

Business Wire (Mar 18, 2013)
XenoPort Reports Fourth Quarter and Year-End 2012 Financial Results

Business Wire (Mar 11, 2013)
XenoPort to Release Fourth Quarter and Year-End Financial Results on March 11, 2013

Business Wire (Mar 4, 2013)
XenoPort Announces New Employment Inducement Awards

Business Wire (Mar 4, 2013)
XenoPort to Present at the Cowen and Company 33rd Annual Health Care Conference

Business Wire (Mar 1, 2013)
XenoPort to Present at Upcoming Healthcare Conferences

Business Wire (Feb 19, 2013)
XenoPort Announces New Employment Inducement Awards

Business Wire (Feb 4, 2013)
XenoPort Announces New Employment Inducement Awards

Business Wire (Jan 4, 2013)
XenoPort Announces New Employment Inducement Award

Business Wire (Dec 7, 2012)
XenoPort to Present at the 24th Annual Piper Jaffray Health Care Conference

Business Wire (Nov 16, 2012)
London Markets: G4S leads U.K. stock lower in choppy trade

at MarketWatch.com (Nov 8, 2012)
XenoPort and GlaxoSmithKline Mutually Agree to Terminate Their Collaboration on Horizant

Business Wire (Nov 8, 2012)
XenoPort Announces New Employment Inducement Award

Business Wire (Nov 2, 2012)

XNPT vs. ETF Alternatives

Company Description

Currently, there's no company description for XNPT.

Sector: Healthcare

Industry: Biotechnology

Country: United States

Red Acre Investments
Binary Event Watch April 2013 - Part II http://bit.ly/114CVMl ... $RPTP $AVEO $DCTH $VVUS $SRPT $PFE $DRRX $PTIE $TTNP $XNPT $EXAS
Apr 12, 12:25 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Red Acre Investments
April binary event watch pt2 $PFE $RPTP $TTNP $AVEO $DCTH $PFE $SRPT $VVUS $AGN $DRRX $PTIE $XNPT $EXAS get it free: http://bit.ly/10SbDco
Apr 11, 7:03 PM
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Ryan Mallory
8 High Volume Breakout Plays http://bit.ly/PjGA4L BKD FST VC CLSN GPS XNPT FRAN KORS Z
8/17/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Scott Matusow
$PGNX has a lot of catalysts coming, should see a run to near 10 leading up to it. Refer to my call on $XNPT #EPICSUCCESS
5/24/12
Reply (2)

• !Report Abuse
View all 2 replies
Cdonecker: Like what I've read so far on PGNX. Looks like they are developing a drug that uses the same method as CLDX 's.
5/25/12
• !Report Abuse
Scott Matusow: and they already turn a profit, bringing in nice revenue, undervalued based on Market cap.
5/25/12
• !Report Abuse
Add a reply...

140 characters

Jim Van Meerten
XNPT - 100% Barchart technical buy signal - 10 new highs and up 31.26% in the past month - Relative Strength Index 68.90%
5/18/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Scott Matusow
Successful call $XNPT I gave in a recent article@ http://bit.ly/KclEoU called for $1.50 higher than $4.50 Bidding $6.15 pre market
5/15/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Scott Matusow
Getting close to my prediction for $XNPT I gave in a recent article @ http://seekingalpha.com/a/a8l7
5/12/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Scott Matusow
I gave my twitter followers $XNPT long before the market opened at $4.51 Follow me on twitter at my SA profile page
4/4/12
Reply (5)

• !Report Abuse
View all 5 replies
amitschele: STOCKS. HEAT. CLNT. WOW.
4/4/12
• !Report Abuse
Aloha96815: must be nice.
4/4/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
$XNPT up a lot more now. wow! well it should be, its grossly undervalued anyways
4/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

Scott Matusow
As I said, $XNPT is up 11 cents in a down market. drug approval date approaching. up market means move to near $5
4/4/12
Reply

• !Report Abuse
View all 0 replies
Add a reply...

140 characters

LATEST REPLIES

Scott Matusow
$PGNX has a lot of catalysts coming, should see a run to near 10 leading up to it. Refer to my call on $XNPT #EPICSUCCESS
5/24/12
Reply (2)

• !Report Abuse
View all 2 replies
Cdonecker: Like what I've read so far on PGNX. Looks like they are developing a drug that uses the same method as CLDX 's.
5/25/12
• !Report Abuse
Scott Matusow: and they already turn a profit, bringing in nice revenue, undervalued based on Market cap.
5/25/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
Looking for $XNPT to start to move up, pre run up to PDUFA date of June 9th. similar to $HZNP
4/4/12
Reply (5)

• !Report Abuse
View all 5 replies
Scott Matusow: No I don't. I think its manipulation orchestrated by Fed on purpose to get equities/commodities low enough to do another QE.
4/10/12
• !Report Abuse
Scott Matusow: meaning that Bernake knew the jobs report, yet still gave signal, 'no QE' takes prices down, so an inflative QE does not over heat pricing
4/10/12
• !Report Abuse
Add a reply...

140 characters

Scott Matusow
I gave my twitter followers $XNPT long before the market opened at $4.51 Follow me on twitter at my SA profile page
4/4/12
Reply (5)

• !Report Abuse
View all 5 replies
amitschele: STOCKS. HEAT. CLNT. WOW.
4/4/12
• !Report Abuse
Aloha96815: must be nice.
4/4/12
• !Report Abuse
Add a reply...

140 characters

freefdawatchlist
Check out upcoming Fda approval Dates http://bit.ly/H6kqQR $ARNA, $RGEN, $XNPT, $SLXP, $GILD, $ALXA, $PLX,$VVUS, $AMGN,$FURX,$CTIC,$VRTX
4/1/12
Reply (3)

• !Report Abuse
View all 3 replies
freefdawatchlist: don't buy more, because if fda delay it by 3 month, the stock may drop. Check out other stock which haven't rallied up till now.
4/1/12
• !Report Abuse
phemale60: VVUS's Avanafil up for FDA approval late April also. Any info about it? I appreciate your insight!
4/1/12
• !Report Abuse
Add a reply...

140 characters

XNPT XenoPort, Inc.

XNPT

XenoPort, Inc.